aTyr Pharma (LIFE) Files $75M Mixed Shelf
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- S&P 500, Nasdaq drop as tech megacap declines outweigh upbeat Micron forecast
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- IBM surges on unveiling sub-1nm chip technology breakthrough
- 'Long-term deals significant positive for stock:' Analysts react to Micron results
aTyr Pharma (LIFE) Misses Q2 EPS by 13c
August 10, 2021 4:25 PM EDTaTyr Pharma (NASDAQ: LIFE) reported Q2 EPS of ($0.64), $0.13 worse than the analyst estimate of ($0.51).
Cash, cash equivalents and investments as of June 30, 2021 were $44.1 million.
We recently completed the last subject visit in our Phase 1b/2a proof-of-concept study of our lead therapeutic candidate,... More
